Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Antisecretory factor (AF) is a 41 kDa endogenous protein, also known as the S5a (or Rpn10) subunit of the 19S regulatory particle of the 26S proteasome (UniProt P55036). It is found in most tissues and body fluids and is characterized by its potent antisecretory and anti-inflammatory properties. AF regulates fluid and ion transport across cell membranes, particularly in the intestinal epithelium, by inhibiting chloride secretion and stabilizing tight junction proteins like ZO-1 and occludin. Its production can be induced by specific dietary triggers, such as specially processed cereals (SPC), or it can be administered exogenously via AF-enriched egg yolk (Salovum) or synthetic peptide fragments like AF-16. Clinically, the AF system is targeted for the treatment of secretory diarrhea, inflammatory bowel disease, and conditions involving abnormal fluid pressure, such as Meniere's disease and glaucoma. Additionally, in oncology, its role as a proteasome subunit (PSMD4) makes it a target for inhibition in diseases like multiple myeloma and chemoresistant colorectal cancer, where its blockade leads to the accumulation of polyubiquitinated proteins and apoptosis.
Inhibition of chloride ion secretion and stimulation of water absorption in the intestinal epithelium; stabilization of tight junction proteins like ZO-1 and occludin; inhibition of GABAergic signaling in the enteric nervous system; as a proteasome subunit, it facilitates the degradation of ubiquitinated proteins by acting as a ubiquitin receptor.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antisecretory factor (AF) (AF).